Skip to main content
NCBI home page
Gut logoLink to Gut
. 1975 May;16(5):379–391. doi: 10.1136/gut.16.5.379

The hypercholesterolaemia of obstructive jaundice.

N McIntyre, D S Harry, A J Pearson
PMCID: PMC1411059  PMID: 166902

Full text

PDF
379

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AHRENS E. H., Jr, KUNKEL H. G. The relationship between serum lipids and skin xanthomata in 18 patients with primary biliary cirrhosis. J Clin Invest. 1949 Nov;28(6 Pt 2):1565–1574. doi: 10.1172/JCI102222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BYERS S. O., FRIEDMAN M. Effect of various bile acids on the hypercholesteremia following biliary obstruction in the rat. Am J Physiol. 1952 Jan;168(1):138–139. doi: 10.1152/ajplegacy.1951.168.1.138. [DOI] [PubMed] [Google Scholar]
  3. BYERS S. O., FRIEDMAN M. Independence of phosphatide induced hypercholesteremia and hepatic function. Proc Soc Exp Biol Med. 1956 Jul;92(3):459–462. doi: 10.3181/00379727-92-22510. [DOI] [PubMed] [Google Scholar]
  4. BYERS S. O., FRIEDMAN M. Observations concerning the production and excretion of cholesterol in mammals. V. The relation of biliary retention of cholesterol, distention of the biliary tract, the shunting of bile to the vena cava, and the removal of the gastro-intestinal tract to the hypercholesteremia consequent on biliary obstruction. J Exp Med. 1952 Jan;95(1):19–24. doi: 10.1084/jem.95.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BYERS S. O., FRIEDMAN M., SUGIYAMA T. Mechanism underlying phosphatide-induced hypercholesterolemia. J Biol Chem. 1962 Nov;237:3375–3380. [PubMed] [Google Scholar]
  6. Badin J., Barillec A. Dosage spécifique de l'antistreptolysine O sérique après élimination des lipoprotéines par l'alcool isoamylique. Ann Biol Clin (Paris) 1969 May-Jun;27(5):395–402. [PubMed] [Google Scholar]
  7. Badin J., Barillec A. Effet des lipides de la beta-lipoprotéine humaine normale sur le pouvoir hémolytique de la streptolysine O et de la digitonine. Ann Biol Clin (Paris) 1968 Jan-Feb;26(1):213–229. [PubMed] [Google Scholar]
  8. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  9. Blomhoff J. P. High density lipoproteins in cholestasis. Scand J Gastroenterol. 1974;9(6):591–596. [PubMed] [Google Scholar]
  10. Byers S. O., Friedman M. Probable sources of plasma cholesterol during phosphatide induced hypercholesterolemia. Lipids. 1969 Mar;4(2):123–128. doi: 10.1007/BF02531930. [DOI] [PubMed] [Google Scholar]
  11. Calandra S., Martin M. J., McIntyre N. Plasma lecithin: cholesterol acyltransferase activity in liver disease. Eur J Clin Invest. 1971 May;1(5):352–360. doi: 10.1111/j.1365-2362.1971.tb00642.x. [DOI] [PubMed] [Google Scholar]
  12. Calandra S., Martin M. J., O'Shea M. J., McIntyre N. The effect of experimental biliary obstruction on the structure and lipid content of rat erythrocytes. Biochim Biophys Acta. 1972 Mar 23;260(3):424–432. doi: 10.1016/0005-2760(72)90057-4. [DOI] [PubMed] [Google Scholar]
  13. Charache S., Margolis S. Effect of plasma from patients with liver disease on resistance of red blood cells to lysis by saponin. J Lab Clin Med. 1969 Jun;73(6):951–955. [PubMed] [Google Scholar]
  14. Cooper A. D., Jones A. L., Koldinger R. E., Ockner R. K. Selective biliary obstruction: a model for the study of lipid metabolism in cholestasis. Gastroenterology. 1974 Apr;66(4):574–585. [PubMed] [Google Scholar]
  15. Cooper A. D., Ockner R. K. Studies of hepatic cholesterol synthesis in experimental acute biliary obstruction. Gastroenterology. 1974 Apr;66(4):586–595. [PubMed] [Google Scholar]
  16. Cooper R. A. Lipids of human red cell membrane: normal composition and variability in disease. Semin Hematol. 1970 Jul;7(3):296–322. [PubMed] [Google Scholar]
  17. DATTA D. V., SHERLOCK S. Treatment of pruritus of obstructive jaundice with cholestyramine. Br Med J. 1963 Jan 26;1(5325):216–219. doi: 10.1136/bmj.1.5325.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. DI LUZIO N. R., ZILVERSMIT D. B. Effect of intravenous phospholipid and Triton on lipids of normal and ethanol-treated rats. Am J Physiol. 1960 Dec;199:991–994. doi: 10.1152/ajplegacy.1960.199.6.991. [DOI] [PubMed] [Google Scholar]
  19. Dietschy J. M., Siperstein M. D. Cholesterol synthesis by the gastrointestinal tract: localization and mechanisms of control. J Clin Invest. 1965 Aug;44(8):1311–1327. doi: 10.1172/JCI105237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. EDER H. A., RUSS E. M., PRITCHETT R. A. R., WILBER M. M., BARR D. P. Protein-lipid relationships in human plasma: in biliary cirrhosis, obstructive jaundice, and acute hepatitis. J Clin Invest. 1955 Jul;34(7 Pt 1):1147–1162. doi: 10.1172/JCI103163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. FREDRICKSON D. S., LOUD A. V., HINKELMAN B. T., SCHNEIDER H. S., FRANTZ I. D., Jr The effect of ligation of the common bile duct on cholesterol synthesis in the rat. J Exp Med. 1954 Jan 1;99(1):43–53. doi: 10.1084/jem.99.1.43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. FRIEDMAN M., BYERS S. O. Hypercholesteremic roles of plasma cholate and phospholipid in biliary obstruction. Am J Physiol. 1957 Dec;191(3):551–554. doi: 10.1152/ajplegacy.1957.191.3.551. [DOI] [PubMed] [Google Scholar]
  23. FRIEDMAN M., BYERS S. O. Source of excess plasma cholesterol in phosphatide-induced hypercholesteremia. Am J Physiol. 1958 Oct;195(1):185–188. doi: 10.1152/ajplegacy.1958.195.1.185. [DOI] [PubMed] [Google Scholar]
  24. FRIEDMAN M., BYERS S. Interrelationship of plasma cholate and phospholipid concentrations and their resultant effect on plasma cholesterol in biliary obstruction. Am J Physiol. 1957 Feb;188(2):337–341. doi: 10.1152/ajplegacy.1957.188.2.337. [DOI] [PubMed] [Google Scholar]
  25. FURMAN R. H., CONRAD L. L. Ultracentrifugal characterization of the lipoprotein spectrum in obstructive jaundice: studies of serum lipid relationships in intra-and extrahepatic biliary obstruction. J Clin Invest. 1957 May;36(5):713–722. doi: 10.1172/JCI103474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Forte T., Nichols A., Glomset J., Norum K. The ultrastructure of plasma lipoproteins in lecithin:cholesterol acyltransferase deficiency. Scand J Clin Lab Invest Suppl. 1974;137:121–132. [PubMed] [Google Scholar]
  27. Forte T., Norum K. R., Glomset J. A., Nichols A. V. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: structure of low and high density lipoproteins as revealed by elctron microscopy. J Clin Invest. 1971 May;50(5):1141–1148. doi: 10.1172/JCI106586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Gjone E., Blomhoff J. P. Plasma lecithin-cholesterol acyltransferase in obstructive jaundice. Scand J Gastroenterol. 1970;5(4):305–308. [PubMed] [Google Scholar]
  29. Gjone E., Orning O. M. Plasma phospholipids in patients with liver disease. A quantitative thin layer chromatographic study. Scand J Clin Lab Invest. 1966;18(2):209–216. doi: 10.3109/00365516609051816. [DOI] [PubMed] [Google Scholar]
  30. Glomset J. A., Norum K. R., King W. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: lipid composition and reactivity in vitro. J Clin Invest. 1970 Oct;49(10):1827–1837. doi: 10.1172/JCI106400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Glomset J. A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed] [Google Scholar]
  32. Hamilton R. L., Havel R. J., Kane J. P., Blaurock A. E., Sata T. Cholestasis: lamellar structure of the abnormal human serum lipoprotein. Science. 1971 Apr 30;172(3982):475–478. doi: 10.1126/science.172.3982.475. [DOI] [PubMed] [Google Scholar]
  33. Harry D. S., Dini M., McIntyre N. Effect of cholesterol feeding and biliary obstruction on hepatic cholesterol biosynthesis in the rat. Biochim Biophys Acta. 1973 Jan 19;296(1):209–220. doi: 10.1016/0005-2760(73)90061-1. [DOI] [PubMed] [Google Scholar]
  34. KUNKEL H. G., AHRENS E. H., Jr The relationship between serum lipids and the electrophoretic pattern, with particular reference to patients with primary biliary cirrhosis. J Clin Invest. 1949 Nov;28(6 Pt 2):1575–1579. doi: 10.1172/JCI102223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. LINDSEY C. A., Jr, WILSON J. D. EVIDENCE FOR A CONTRIBUTION BY THE INTESTINAL WALL TO THE SERUM CHOLESTEROL OF THE RAT. J Lipid Res. 1965 Apr;6:173–181. [PubMed] [Google Scholar]
  36. Man E. B., Kartin B. L., Durlacher S. H., Peters J. P. THE LIPIDS OF SERUM AND LIVER IN PATIENTS WITH HEPATIC DISEASES. J Clin Invest. 1945 Sep;24(5):623–643. doi: 10.1172/JCI101644. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. McIntyre N., Calandra S., Pearson A. J. Lipid and lipoprotein abnormalities in liver disease: the possible role of lecithin: cholesterol acyltransferase deficiency. Scand J Clin Lab Invest Suppl. 1974;137:115–120. [PubMed] [Google Scholar]
  38. Müller P., Felin R., Lambrecht J., Agostini B., Wieland H., Rost W., Seidel D. Hypertriglyceridaemia secondary to liver disease. Eur J Clin Invest. 1974 Dec 5;4(6):419–428. doi: 10.1111/j.1365-2362.1974.tb00415.x. [DOI] [PubMed] [Google Scholar]
  39. Norum K. R., Glomset J. A., Nichols A. V., Forte T. Plasma lipoproteins in familial lecithin: cholesterol acyltransferase deficiency: physical and chemical studies of low and high density lipoproteins. J Clin Invest. 1971 May;50(5):1131–1140. doi: 10.1172/JCI106585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. PETERSEN V. P. The individual plasma phospholipids in obstructive jaundice. Acta Med Scand. 1953;144(5):345–353. doi: 10.1111/j.0954-6820.1953.tb15705.x. [DOI] [PubMed] [Google Scholar]
  41. Pertsemlidis D., Panveliwalla D., Ahrens E. H., Jr Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man. Gastroenterology. 1974 Apr;66(4):565–573. [PubMed] [Google Scholar]
  42. Quarfordt S. H., Oelschlaeger H., Krigbaum W. R., Jakoi L., Davis R. Effect of biliary obstruction on canine plasma and biliary lipids. Lipids. 1973 Sep;8(9):522–530. doi: 10.1007/BF02531988. [DOI] [PubMed] [Google Scholar]
  43. Quarfordt S. H., Oelschlaeger H., Krigbaum W. R. Liquid crystalline lipid in the plasma of humans with biliary obstruction. J Clin Invest. 1972 Aug;51(8):1979–1988. doi: 10.1172/JCI107004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. RUSS E. M., RAYMUNT J., BARR D. P. Lipoproteins in primary biliary cirrhosis. J Clin Invest. 1956 Feb;35(2):133–144. doi: 10.1172/JCI103257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ritland S., Blomhoff J. P., Gjone E. Lecithin: cholesterol acyl-transferase and lipoprotein-X in liver disease. Clin Chim Acta. 1973 Dec 12;49(2):251–259. doi: 10.1016/0009-8981(73)90299-4. [DOI] [PubMed] [Google Scholar]
  46. SAKAKIDA H., SHEDIAC C. C., SIPERSTEIN M. D. EFFECT OF ENDOGENOUS AND EXOGENOUS CHOLESTEROL ON THE FEEDBACK CONTROL OF CHOLESTEROL SYNTHESIS. J Clin Invest. 1963 Sep;42:1521–1528. doi: 10.1172/JCI104836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Schaffner E. Serum cholesterol in primary biliary cirrhosis. Gastroenterology. 1969 Jun;56(6):1111–1113. [PubMed] [Google Scholar]
  48. Schaffner F. Paradoxical elevation of serum cholesterol by clofibrate in patients with primary biliary cirrhosis. Gastroenterology. 1969 Sep;57(3):253–255. [PubMed] [Google Scholar]
  49. Seidel D., Alaupovic P., Furman R. H. A lipoprotein characterizing obstructive jaundice. I. Method for quantitative separation and identification of lipoproteins in jaundiced subjects. J Clin Invest. 1969 Jul;48(7):1211–1223. doi: 10.1172/JCI106085. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Seidel D., Alaupovic P., Furman R. H., McConathy W. J. A lipoprotein characterizing obstructive jaundice. II. Isolation and partial characterization of the protein moieties of low density lipoproteins. J Clin Invest. 1970 Dec;49(12):2396–2407. doi: 10.1172/JCI106459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Seidel D., Greten H., Geisen H. P., Wengeler H., Wieland H. Further aspects on the characterization of high and very low density lipoproteins in patients with liver disease. Eur J Clin Invest. 1972 Aug;2(5):359–364. doi: 10.1111/j.1365-2362.1972.tb00662.x. [DOI] [PubMed] [Google Scholar]
  52. Stakeberg H., Lundborg H., Scherstén T. Rate of in vitro incorporation of precursors into hepatic lipids and proteins in patients with extrahepatic cholestasis. Eur J Clin Invest. 1974 Dec 5;4(6):399–403. doi: 10.1111/j.1365-2362.1974.tb00412.x. [DOI] [PubMed] [Google Scholar]
  53. Stein O., Alkan M., Stein Y. Obstructive jaundice lipoprotein particles studied in ultrathin sections of livers of bile duct-ligated mice. Lab Invest. 1973 Aug;29(2):166–172. [PubMed] [Google Scholar]
  54. Switzer S. Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction. J Clin Invest. 1967 Nov;46(11):1855–1866. doi: 10.1172/JCI105676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Thomas P. K., Walker J. G. Xanthomatous neuropathy in primary biliary cirrhosis. Brain. 1965 Dec;88(5):1079–1088. doi: 10.1093/brain/88.5.1079. [DOI] [PubMed] [Google Scholar]
  56. Turnberg L. A., Mahoney M. P., Gleeson M. H., Freeman C. B., Gowenlock A. H. Plasmaphoresis and plasma exchange in the treatment of hyperlipaemia and xanthomatous neuropathy in patients with primary biliary cirrhosis. Gut. 1972 Dec;13(12):976–981. doi: 10.1136/gut.13.12.976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Utermann G., Schoenborn W., Langer K. H., Dieker P. Lipoproteins in LCAT-deficiency. Humangenetik. 1972;16(4):295–306. doi: 10.1007/BF00283977. [DOI] [PubMed] [Google Scholar]
  58. VAN ITALLIE T. B., HASHIM S. A., CRAMPTON R. S., TENNENT D. M. The treatment of pruritus and hypercholesteremia of primary biliary cirrhosis with cholestyramine. N Engl J Med. 1961 Sep 7;265:469–474. doi: 10.1056/NEJM196109072651004. [DOI] [PubMed] [Google Scholar]
  59. Weis H. J., Dietschy J. M. Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedback. J Clin Invest. 1969 Dec;48(12):2398–2408. doi: 10.1172/JCI106206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Wilson J. D., Reinke R. T. Transfer of locally synthesized cholesterol from intestinal wall to intestinal lymph. J Lipid Res. 1968 Jan;9(1):85–92. [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES